Clinical trial
Melatonin in Patients With Multiple Sclerosis (MS).
NCT03498131
Study timeline
Study start (actual)2018-05-09Date precision: day
Registry last updated2025-03-30
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Relapsing Remitting Multiple Sclerosisunresolved
Interventions
3 mg MelatoninDRUG
5 mg MelatoninDRUG
Sponsors & collaborators
Providence Health & Serviceslead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03498131 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.